Delivery Order SPE2DB22D1106-SPE2DB24FEXX1
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The contract has a ceiling value of $1,337.70 and an ultimate completion date of July 31, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,662.65 firm fixed-price contract is for the delivery of 60 tablets of the medication valganciclovir 450 mg. The contract has a performance period through January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and there is no...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 60 count bottles of 450 mg valganciclovir tablets. This $2,050.03 award has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and provides a wide range of pharmaceutical products and medical...
This federal contract award, valued at $3,507.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of 450 mg Valganciclovir tablets, a medication used for the treatment of cytomegalovirus (CMV) infections. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 31, 2024. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,395.13 Firm Fixed Price delivery order is for the supply of 60 units of the prescription drug Valganciclovir 450 mg tablets. The contract has an ultimate completion date of February 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order with a ceiling value of $1,111.53 for the supply of valganciclovir hydrochloride 50 mg/mL oral solution. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military treatment programs and facilities. The delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,664.05 firm fixed price delivery order is for the supply of 60 units of Valganciclovir 450 mg tablets. The contract has a completion date of January 16, 2024. AmerisourceBergen Drug Corp has previously received numerous federal contract awards from DLA to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,147.05 firm fixed-price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the supply of Valganciclovir HCL 50 mg/ml, 88 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, with a ceiling value of $1,482.04. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,948.63 firm fixed-price delivery order is for the supply of 4558106928 valganciclovir HCL 50 mg/ml medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 15, 2022. No set-aside was used for this open competition contract. AmerisourceBergen holds a $999,999,999...